DSpace at RU >

Browsing by Author Schaik, R.H. van

Full Text	Issue Date	Title	Author(s)
	2011	Dextromethorphan as a phenotyping test to predict endoxifen exposure in patients on tamoxifen treatment	Graan, A.J. de; Teunissen, S.F.; Vos, F.Y. de; Loos, W.J.; Schaik, R.H. van, et al
	2011	Pharmacogenetics: from bench to byte--an update of guidelines	Swen, J.J.; Nijenhuis, M.; Boer, A. de; Grandia, L.; Maitland-van der Zee, A.H., et al
	2011	The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients	Schaik, R.H. van; Kok, M. de; Sweep, F.C.; Vliet, M. van; Fessem, M. van, et al
	2010	Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir.	Luin, M. van; Ende, M.E. van der; Richter, C.; Visser, M. de; Faraj, D., et al
	2009	Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin.	Luin, M. van; Brouwer, A.E.; Ven, A.J.A.M. van der; Lange, W. de; Schaik, R.H. van, et al
	2009	Genotypes associated with reduced activity of VKORC1 and CYP2C9 and their modification of acenocoumarol anticoagulation during the initial treatment period.	Teichert, M.; Schaik, R.H. van; Hofman, A.; Uitterlinden, A.G.; Smet, P.A.G.M. de, et al
	2009	A genome-wide association study of acenocoumarol maintenance dosage.	Teichert, M.; Eijgelsheim, M.; Rivadeneira, F.; Uitterlinden, A.G.; Schaik, R.H. van, et al
	2008	Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study.	Teichert, M.; Visser, L.E.; Schaik, R.H. van; Hofman, A.; Uitterlinden, A.G., et al
	2005	Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants.	Visser, L.E.; Schaik, R.H. van; Vliet, M. van; Trienekens, P.H.; Smet, P.A.G.M. de, et al
	2004	The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon.	Visser, L.E.; Vliet, M. van; Schaik, R.H. van; Kasbergen, A.A.H.; Smet, P.A.G.M. de, et al
	2004	The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon.	Visser, L.E.; Schaik, R.H. van; Vliet, M. van; Trienekens, P.H.; Smet, P.A.G.M. de, et al